BDBM521725 US11149056, Compound U6472

SMILES C[C@H](CCC(C)(O)C(F)(F)F)[C@H]1CC[C@H]2[C@@H]3[C@H](C)C=C4C[C@@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C

InChI Key InChIKey=ZNZMDQAVUSQVAG-JZRKJVEGSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 521725   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Sage Therapeutics

US Patent
LigandPNGBDBM521725(US11149056, Compound U6472)
Affinity DataEC50:  22nMAssay Description:Cells are transferred as suspension in serum-free medium to the QPatch HTX system and kept in the cell storage tank/stirrer during experiments. All s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2A(Homo sapiens (Human))
Sage Therapeutics

US Patent
LigandPNGBDBM521725(US11149056, Compound U6472)
Affinity DataEC50:  13nMAssay Description:Cells are transferred as suspension in serum-free medium to the QPatch HTX system and kept in the cell storage tank/stirrer during experiments. All s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent